Tectonic Company Equity Multiplier from 2010 to 2024

TECX Stock   50.56  3.00  6.31%   
Tectonic Therapeutic, Company Equity Multiplier yearly trend continues to be fairly stable with very little volatility. Company Equity Multiplier is likely to outpace its year average in 2024. During the period from 2010 to 2024, Tectonic Therapeutic, Company Equity Multiplier regression line of annual values had r-squared of  0.0001 and arithmetic mean of  1.26. View All Fundamentals
 
Company Equity Multiplier  
First Reported
2010-12-31
Previous Quarter
1.06706847
Current Value
1.4
Quarterly Volatility
0.24884428
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Tectonic Therapeutic, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tectonic Therapeutic,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.3 M, Other Operating Expenses of 77.8 M or Research Development of 54.5 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.6. Tectonic financial statements analysis is a perfect complement when working with Tectonic Therapeutic, Valuation or Volatility modules.
  
Check out the analysis of Tectonic Therapeutic, Correlation against competitors.
For more information on how to buy Tectonic Stock please use our How to Invest in Tectonic Therapeutic, guide.

Latest Tectonic Therapeutic,'s Company Equity Multiplier Growth Pattern

Below is the plot of the Company Equity Multiplier of Tectonic Therapeutic, over the last few years. It is Tectonic Therapeutic,'s Company Equity Multiplier historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tectonic Therapeutic,'s overall financial position and show how it may be relating to other accounts over time.
Company Equity Multiplier10 Years Trend
Very volatile
   Company Equity Multiplier   
       Timeline  

Tectonic Company Equity Multiplier Regression Statistics

Arithmetic Mean1.26
Geometric Mean1.24
Coefficient Of Variation19.73
Mean Deviation0.14
Median1.22
Standard Deviation0.25
Sample Variance0.06
Range1.0204
R-Value0.01
Mean Square Error0.07
R-Squared0.0001
Significance0.97
Slope0.0006
Total Sum of Squares0.87

Tectonic Company Equity Multiplier History

2024 1.4
2022 1.38
2021 1.2
2020 1.07
2019 1.08
2018 1.09
2017 2.09

About Tectonic Therapeutic, Financial Statements

Tectonic Therapeutic, investors use historical fundamental indicators, such as Tectonic Therapeutic,'s Company Equity Multiplier, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Tectonic Therapeutic,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Company Equity Multiplier 1.07  1.40 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Tectonic Stock Analysis

When running Tectonic Therapeutic,'s price analysis, check to measure Tectonic Therapeutic,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tectonic Therapeutic, is operating at the current time. Most of Tectonic Therapeutic,'s value examination focuses on studying past and present price action to predict the probability of Tectonic Therapeutic,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tectonic Therapeutic,'s price. Additionally, you may evaluate how the addition of Tectonic Therapeutic, to your portfolios can decrease your overall portfolio volatility.